INDEPENDENT THINKING. WHOLE-FOOD LIVING.NO ANIMALS / NO OIL
THENANODIET
← THE STUDY LIBRARY

Clinical trial / 2016

Flaxseed added to lifestyle modification improved liver markers in fatty liver disease

In an open-label trial with 50 adults having non-alcoholic fatty liver disease, participants received either lifestyle changes alone or with 30 grams daily of milled flaxseed for 12 weeks. Both groups improved, but flaxseed produced greater reductions in ALT (-11.12 vs -3.7 U/L), AST (-8.29 vs -4 U/L), GGT (-15.7 vs -2.62 U/L), fibrosis (-1.26 vs -0.77 kPa), and steatosis (-47 vs -15.45 dB/m). Body weight and insulin resistance also decreased more with flaxseed.

Study type
Randomized controlled trial
Who was studied
50 patients with non-alcoholic fatty liver disease
What was measured
Liver enzymes, hepatic fibrosis and steatosis, body weight, insulin resistance

THE PAPER

Flaxseed supplementation in non-alcoholic fatty liver disease: a pilot randomized, open labeled, controlled study.

Yari Z, Rahimlou M, Eslamparast T, Ebrahimi-Daryani N, Poustchi H, Hekmatdoost A. Int J Food Sci Nutr, 2016.

PubMed 26983396 ↗DOI 10.3109/09637486.2016.1161011 ↗

Diabetes & blood sugarWeight & appetiteOther health

This note is written from the study's published abstract. It summarizes what the authors reported; it is not medical advice and does not replace reading the full paper.